Lasse Jensen

Lasse Jensen

Linköpings Universitet

H-index: 33

Europe-Sweden

About Lasse Jensen

Lasse Jensen, With an exceptional h-index of 33 and a recent h-index of 28 (since 2020), a distinguished researcher at Linköpings Universitet, specializes in the field of hypoxia, retinopathy, zebrafish, angiogenesis, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer

RhoB expression associated with chemotherapy response and prognosis in colorectal cancer

Loss of REP1 impacts choroidal melanogenesis and vasculogenesis in choroideremia

Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes

VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway

Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐β‐myoCAF‐Dependent Mechanism

APR-246 enhances colorectal cancer sensitivity to radiotherapy

Novel zebrafish patient-derived tumor xenograft methodology for evaluating efficacy of immune-stimulating BCG therapy in urinary bladder cancer

Lasse Jensen Information

University

Position

Head of the zebrafish laboratory

Citations(all)

4337

Citations(since 2020)

2529

Cited By

2907

hIndex(all)

33

hIndex(since 2020)

28

i10Index(all)

65

i10Index(since 2020)

63

Email

University Profile Page

Linköpings Universitet

Google Scholar

View Google Scholar Profile

Lasse Jensen Skills & Research Interests

hypoxia

retinopathy

zebrafish

angiogenesis

cancer

Top articles of Lasse Jensen

Title

Journal

Author(s)

Publication Date

Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer

NPJ Precision Oncology

Gabriel Lindahl

Sebastian Fjellander

Karthik Selvaraj

Malin Vildeval

Zaheer Ali

...

2024/2/27

RhoB expression associated with chemotherapy response and prognosis in colorectal cancer

Cancer Cell International

Maria Kopsida

Na Liu

Angeliki Kotti

Jing Wang

Lasse Jensen

...

2024/2/15

Loss of REP1 impacts choroidal melanogenesis and vasculogenesis in choroideremia

Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease

Hajrah Sarkar

Dhani Tracey-White

Ahmed M Hagag

Thomas Burgoyne

Neelima Nair

...

2024/2/1

Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes

Open Research Europe

Husvinee Sundaramurthi

Valentina Tonelotto

Kieran Wynne

Fiona O'Connell

Eve O’Reilly

...

2023

VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway

Signal Transduction and Targeted Therapy

Chunsik Lee

Rongyuan Chen

Guangli Sun

Xialin Liu

Xianchai Lin

...

2023/8/18

Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐β‐myoCAF‐Dependent Mechanism

Advanced Science

Jieyu Wu

Xu Jing

Qiqiao Du

Xiaoting Sun

Kristian Holgersson

...

2023/8

APR-246 enhances colorectal cancer sensitivity to radiotherapy

Molecular Cancer Therapeutics

Xuqin Xie

Chuanwen Fan

Bin Luo

Jing Zhang

Lasse D Jensen

...

2023/8/1

Novel zebrafish patient-derived tumor xenograft methodology for evaluating efficacy of immune-stimulating BCG therapy in urinary bladder cancer

Cells

Saskia Kowald

Ylva Huge

Decky Tandiono

Zaheer Ali

Gabriela Vazquez-Rodriguez

...

2023/2/3

Allosteric modulation of the CXCR4: CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain

bioRxiv

Eva M García-Cuesta

Pablo Martínez

Karthik Selvaraju

Adrián Miguel Gómez Pozo

Gianluca D’Agostino

...

2023/11/21

Loss of REP1 impacts choroidal melanogenesis in choroideremia

bioRxiv

Hajrah Sarkar

Dhani Tracey-White

Ahmed M Hagag

Thomas Burgoyne

Lasse D Jensen

...

2023

Up-to-date molecular medicine strategies for management of ocular surface neovascularization

Yunlong Yang

Junmu Zhong

Dongmei Cui

Lasse D Jensen

2023/9/7

Uveal melanoma cell line proliferation is inhibited by ricolinostat, a histone deacetylase inhibitor

Cancers

Husvinee Sundaramurthi

Sandra García-Mulero

Valentina Tonelotto

Kayleigh Slater

Simone Marcone

...

2022/2/3

Dietary ketone body–escalated histone acetylation in megakaryocytes alleviates chemotherapy-induced thrombocytopenia

Science translational medicine

Sisi Xie

Chenyu Jiang

Meng Wu

Ying Ye

Biying Wu

...

2022/11/30

Opposing inflammatory biomarker responses to sleep disruption in cancer patients before and during oncological therapy

Frontiers in Neuroscience

Delmy Oliva

Bengt-Åke Andersson

Freddi Lewin

Lasse D Jensen

2022/9/21

Exploring The Therapeutic Potential of Ergolide as An Anti-Cancer Agent for Uveal Melanoma

Investigative Ophthalmology & Visual Science

Valentina Tonelotto

Husvinee Sundaramurthi

Simone Marcone

Lasse Jensen

Giricz Zoltán

...

2022/6/1

Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer

Journal of Experimental & Clinical Cancer Research

Zaheer Ali

Malin Vildevall

Gabriela Vazquez Rodriguez

Decky Tandiono

Ioannis Vamvakaris

...

2022/2/9

Microbiomics in collusion with the nervous system in carcinogenesis: Diagnosis, Pathogenesis and Treatment

Rodney Hull

Georgios Lolas

Stylianos Makrogkikas

Lasse D Jensen

Konstantinos N Syrigos

...

2021/10/11

Relapse of pathological angiogenesis: functional role of the basement membrane and potential treatment strategies

Anthony Mukwaya

Lasse Jensen

Neil Lagali

2021/2

Sensitivity of acute myelocytic leukemia cells to the dienone compound VLX1570 is associated with inhibition of the ubiquitin-proteasome system

Biomolecules

Karthik Selvaraju

Kourosh Lotfi

Johannes Gubat

Maria Miquel

Amanda Nilsson

...

2021/9/10

A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients

Lasse D Jensen

Delmy Oliva

Bengt-Åke Andersson

Freddi Lewin

2021/12

See List of Professors in Lasse Jensen University(Linköpings Universitet)